Table III.
Metabolites accumulating to higher levels in tt5 seeds than in wild-type seeds
Alignment and comparison of Ler and tt5 metabolite profiles revealed 78 differential features (fold change ≥ 2, P ≤ 0.05), of which 42 could be putatively annotated. Quant., Quantifier. Hex, Hexose; NC, naringenin chalcone; SC, sinapoylcholine.
No. | Compound | Annotation Levela | Retention Time | Quant. Ion | ESI-FTICR-MSb (Fraction) | No. of Detected Differential Features | Experiment 1
|
Experiment 2
|
||
---|---|---|---|---|---|---|---|---|---|---|
Fold Change | −log10 (P) | Fold Change | −log10 (P) | |||||||
min | m/z | |||||||||
39 | Choline | 1c | 5.8 | 104.11 | – | 2 | 2.4 | 4.4 | 5.3 | 4.8 |
20 | 4-Hydroxybenzoylcholine | 1d | 10.5 | 165.06 | – | 2 | 2.3 | 1.9 | 7.8 | 5.2 |
T40 | SC dimer isomer 3 | 3 | 19.3 | 310.17 | – | 1 | n.d. in Ler | – | n.d. in Ler | – |
41 | Feruloylcholine | 1d | 20.8 | 221.08 | – | 4 | 3.9 | 1.9 | 3.5 | 2.8 |
T42 | Dihydro NC-(Hex)2 | 2e | 28.6 | 275.10 | III | 6 | n.d. in Ler | – | n.d. in Ler | – |
T43 | Dihydro NC-Hex isomer 1 | 2e | 33.8 | 275.10 | III | 5 | n.d. in Ler | – | n.d. in Ler | – |
T44 | Dihydro NC-Hex isomer 2 | 2e | 35.7 | 275.10 | III | 7 | n.d. in Ler | – | n.d. in Ler | – |
T45 | NC-(Hex)2 | 2e | 28.7 | 273.08 | III | 4 | n.d. in Ler | – | n.d. in Ler | – |
T46 | NC-Hex isomer 1 | 2e | 32.1 | 273.08 | III | 3 | n.d. in Ler | – | n.d. in Ler | – |
T47 | NC-Hex isomer 2 | 2e | 35.2 | 273.08 | III | 3 | n.d. in Ler | – | n.d. in Ler | – |
T48 | (NC-OH)-Hex | 2f | 32.0 | 289.08 | – | 2 | n.d. in Ler | – | n.d. in Ler | – |
T49 | (NC-OMe)-Hex isomer 1 | 2f | 32.0 | 465.14 | III | 0 | n.d. in Ler | – | n.d. in Ler | – |
T50 | (NC-OMe)-Hex isomer 2 | 2f | 32.9 | 465.14 | III | 2 | n.d. in Ler | – | n.d. in Ler | – |
T34 | 9-(Methylsulfinyl)nonanenitrile | 2g | 33.0 | 202.12 | III | 1 | 4.6 | 3.7 | 5.8 | 5.0 |
Annotation level according to Sumner et al. (2007).
Elemental composition confirmed by direct infusion ESI-FTICR-MS after fractionation. For numbering of fractions, see “Materials and Methods.”
Compound identified with a commercially available standard.
Compound identified with a chemically synthesized standard.
Aglycone putatively annotated with a commercially available standard.
Compound putatively annotated by interpretation and comparison of CID mass spectra of similar known compounds.
Compound described in the literature.